Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

by Element Science

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

These tools are adjacent rather than direct competitors, as they serve different primary functions in cardiac care. The Jewel Patch is a wearable cardioverter defibrillator designed for continuous monitoring and *treatment* of life-threatening arrhythmias, offering immediate intervention. In contrast, the LINQ II is an insertable cardiac monitor focused on long-term, continuous heart rhythm *monitoring* for diagnostic purposes.

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose the Jewel Patch Wearable Cardioverter Defibrillator if your patient requires temporary, immediate protection against sudden cardiac arrest with the capability to deliver therapy. Its water-resistant, discreet, and patch-based design is ideal for high patient compliance during a transitional period or when an implantable device is not yet suitable or feasible.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the LINQ II Insertable Cardiac Monitor if your patient needs long-term, continuous, and highly accurate monitoring for the diagnosis of infrequent or elusive arrhythmias. This insertable device offers up to 4.5 years of monitoring, AI-powered accuracy, remote programming, and MRI compatibility, making it suitable for comprehensive diagnostic management over an extended period, including for pediatric patients.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)	LINQ II Insertable Cardiac Monitor
Deployment	Wearable device with mobile app	Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Jewel (Tool A) offers a patch-based, water-resistant design for continuous wear, including showering, and boasts high patient compliance with a median wear time over 23 hours/day. This wearable approach generally provides a less invasive and more convenient daily experience compared to an insertable device (Tool B) which requires a minor surgical procedure for implantation.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Jewel (Tool A) provides continuous heart monitoring and the ability to *treat* life-threatening arrhythmias by delivering defibrillation therapy. While LINQ II (Tool B) offers advanced, long-term monitoring and AI-powered diagnosis, Jewel's capacity to directly intervene and treat life-threatening events offers a higher level of immediate clinical value for patients at risk of sudden cardiac arrest.

Pricing & Value

Tie

Both tools have non-public pricing, with details typically negotiated directly with healthcare systems. Without transparent pricing information or comparative cost-effectiveness studies, it is impossible to definitively determine which offers superior pricing or overall value. Therefore, a tie is appropriate for this dimension.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic (Tool B's company) is a long-established global medical device leader, founded in 1949, with over 1 million patients having received their ICMs worldwide. This extensive track record, global presence, and large customer base indicate a highly mature and robust enterprise infrastructure for sales, support, and integration, surpassing that of Element Science (Tool A's company).

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Jewel (Tool A) introduces a significant innovation with its patch-based wearable cardioverter defibrillator, offering a novel, discreet, and highly compliant form factor for a life-saving therapy. While LINQ II (Tool B) incorporates advanced AI algorithms and remote capabilities, the fundamental concept of an insertable cardiac monitor is an evolution of existing technology, making the wearable defibrillator patch a more groundbreaking innovation.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic (Tool B's company) is a global medical device giant with a long history and millions of devices in use, strongly implying a comprehensive and well-established support infrastructure, extensive documentation, and training programs. While Element Science (Tool A's company) would provide necessary support, it cannot match the scale and proven global support network of Medtronic.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)	LINQ II Insertable Cardiac Monitor
Device Type/Form Factor	Patch-based wearable cardioverter defibrillator	Insertable Cardiac Monitor
Core Function	Continuous heart monitoring and treatment of life-threatening arrhythmias	Long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias
AI/ML Capability	Machine learning detection algorithm for arrhythmia detection	AccuRhythmu2122 AI algorithms for enhanced accuracy
Water Resistance/Wearability	Water-resistant design for continuous wear, including showering	Not specified
Monitoring Duration	Continuous heart rhythm monitoring	Up to 4.5 years of continuous monitoring
Mobile App	Associated Jewel Mobile App for near real-time therapy information to medical team	MyCareLink Heartu2122 mobile app for data transmission
Treatment Capability	Detects and treats specific life-threatening arrhythmias	Diagnosing arrhythmias
Company	Element Science, Inc.	Medtronic

Videos

Demos, reviews, and walkthroughs featuring Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in the clinical utility of the Jewel Patch WCD compared to the LINQ II ICM?

The Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) is designed for continuous heart monitoring and the *treatment* of life-threatening arrhythmias, delivering therapeutic shocks when detected. In contrast, the LINQ II Insertable Cardiac Monitor (ICM) provides long-term, continuous heart rhythm *monitoring* specifically for diagnosing arrhythmias, without delivering therapeutic intervention.

What are the key differences in the AI capabilities of each device?

The Jewel Patch WCD utilizes a machine learning algorithm for continuous heart monitoring and arrhythmia detection, designed to minimize inappropriate detections and shocks. The LINQ II ICM features AccuRhythmu2122 AI algorithms for enhanced accuracy in diagnosing arrhythmias, including an innovative PVC detection algorithm, and aims to reduce false alerts for conditions like atrial fibrillation and pause.

What is the expected duration of use for each device?

The Jewel Patch WCD is designed for continuous wear, with studies showing a median wear time of over 23 hours per day, and can be worn for up to a week at a time. The LINQ II ICM offers long-term continuous monitoring for up to 4.5 years, providing an extended diagnostic window.

How do these devices facilitate remote patient management and data access for the medical team?

The Jewel Patch WCD uses an associated Jewel Mobile App to transmit near real-time therapy information to the medical team. The LINQ II ICM offers remote programming capability and utilizes the MyCareLink Heartu2122 mobile app or the MyCareLink Relayu2122 home communicator for automatic data transmission to the doctor's office.

Are there differences in the types of arrhythmias each device addresses?

The Jewel Patch WCD is designed to detect and treat specific life-threatening arrhythmias, such as ventricular tachycardia/ventricular fibrillation, indicating a focus on immediate therapeutic intervention for patients at high risk of sudden cardiac arrest. The LINQ II ICM focuses on diagnosing various abnormal heart rhythms, including atrial fibrillation, syncope, and cryptogenic stroke, for long-term diagnostic purposes.

What are the considerations regarding water exposure and discretion for patients using these devices?

The Jewel Patch WCD is water-resistant, allowing for continuous wear during activities like showering, and features a discreet, under-clothing design to enhance patient comfort and compliance. As an insertable device, the LINQ II ICM is placed just under the skin, making it not visible in most patients and inherently discreet, and it is also MRI compatible.